Killing Two Birds with One Stone: Oral Tofacitinib Reverses Alopecia Universalis in a Patient with Plaque Psoriasis

被引：174

作者：

Craiglow, Brittany G. ^{[1
]}

King, Brett A. ^{[1
]}

机构：

[1] Yale Univ, Sch Med, Dept Dermatol, New Haven, CT 06510 USA

来源：

JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2014年 / 134卷 / 12期

关键词：

JANUS KINASE INHIBITOR; C3H/HEJ MICE; AREATA; PREVENTS; EFFICACY; SAFETY; ONSET; JAK3;

D O I：

10.1038/jid.2014.260

中图分类号：

R75 [皮肤病学与性病学];

学科分类号：

100227 [皮肤病学];

摘要：

引用

页码：2988 / 2990

页数：3

共 14 条

[1]

Double-Blind, Placebo-Controlled, Dose-Escalation Study to Evaluate the Pharmacologic Effect of CP-690,550 in Patients With Psoriasis [J].

Boy, Mary G. ;

Wang, Cunshan ;

Wilkinson, Bethanie E. ;

Chow, Vincent Fung-Sing ;

Clucas, Alan T. ;

Krueger, James G. ;

Gaweco, Anderson S. ;

Zwillich, Samuel H. ;

Changelian, Paul S. ;

Chan, Gary .

JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2009, 129 (09) :2299-2302

[2]

Dai Z, 2012, J INVEST DERMATOL, V132, pS106

[3]

Modulation of Innate and Adaptive Immune Responses by Tofacitinib (CP-690,550) [J].

Ghoreschi, Kamran ;

Jesson, Michael I. ;

Li, Xiong ;

Lee, Jamie L. ;

Ghosh, Sarbani ;

Alsup, Jason W. ;

Warner, James D. ;

Tanaka, Masao ;

Steward-Tharp, Scott M. ;

Gadina, Massimo ;

Thomas, Craig J. ;

Minnerly, John C. ;

Storer, Chad E. ;

LaBranche, Timothy P. ;

Radi, Zaher A. ;

Dowty, Martin E. ;

Head, Richard D. ;

Meyer, Debra M. ;

Kishore, Nandini ;

O'Shea, John J. .

JOURNAL OF IMMUNOLOGY, 2011, 186 (07) :4234-4243

[4]

Jabbari A, 2013, J INVEST DERMATOL, V133, P1395

[5]

Jabbari A, 2012, J INVEST DERMATOL, V132, pS104

[6]

TYROSINE PHOSPHORYLATION AND ACTIVATION OF STAT5, STAT3, AND JANUS KINASES BY INTERLEUKIN-2 AND INTERLEUKIN-15 [J].

JOHNSTON, JA ;

BACON, CM ;

FINBLOOM, DS ;

REES, RC ;

KAPLAN, D ;

SHIBUYA, K ;

ORTALDO, JR ;

GUPTA, S ;

CHEN, YQ ;

GIRI, JD ;

OSHEA, JJ .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (19) :8705-8709

[7]

Mackay-Wiggan J., 2014, OPEN LABEL PILOT STU

[8]

Mamolo C., 2013, J Eur Acad Dermatol Venereol

[9]

Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study [J].

Papp, K. A. ;

Menter, A. ;

Strober, B. ;

Langley, R. G. ;

Buonanno, M. ;

Wolk, R. ;

Gupta, P. ;

Krishnaswami, S. ;

Tan, H. ;

Harness, J. A. .

BRITISH JOURNAL OF DERMATOLOGY, 2012, 167 (03) :668-677

[10]

Jak3, severe combined immunodeficiency, and a new class of immunosuppressive drugs [J].

Pesu, M ;

Candotti, F ;

Husa, M ;

Hofmann, SR ;

Notarangelo, LD ;

O'Shea, JJ .

IMMUNOLOGICAL REVIEWS, 2005, 203 :127-142

← 1 2 →